Arora Nevin, Meskill Gerard, Guilleminault Christian
Stanford University Sleep Medicine Division, Redwood City, California, USA.
Sleep Sci. 2015 Nov;8(3):134-42. doi: 10.1016/j.slsci.2015.08.003. Epub 2015 Sep 3.
Obstructive sleep apnea (OSA) is defined by quantifying apneas and hypopneas along with symptoms suggesting sleep disruption. Subtler forms of sleep-disordered breathing can be missed when this criteria is used. Newer technologies allow for non-invasive detection of flow limitation, however consensus classification is needed. Subjects with flow limitation demonstrate electroencephalogram changes and clinical symptoms indicating sleep fragmentation. Flow limitation may be increased in special populations and treatment with nasal continuous positive airway pressure (CPAP) has been shown to improve outcomes. Titrating CPAP to eliminate flow limitation may be associated with improved clinical outcomes compared to treating apneas and hypopneas.
阻塞性睡眠呼吸暂停(OSA)通过量化呼吸暂停和低通气以及提示睡眠中断的症状来定义。使用该标准时,可能会遗漏较轻微形式的睡眠呼吸障碍。新技术允许对气流受限进行无创检测,然而需要达成共识分类。有气流受限的受试者表现出脑电图变化和提示睡眠片段化的临床症状。特殊人群中气流受限可能会增加,并且已证明使用鼻持续气道正压通气(CPAP)治疗可改善预后。与治疗呼吸暂停和低通气相比,滴定CPAP以消除气流受限可能与更好的临床预后相关。